When was Triomi founded?

Triomi was founded in 2010 and raised its 1st funding round 5 years after it was founded.

Where is Triomi located?

Triomi is headquartered in New York City, United States.

Is Triomi a funded company?

Triomi is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Mar 09, 2015.

When was the latest funding round of Triomi?

Triomi's latest funding was a $***** Seed round on Mar 09, 2015, with participation from 1 investor. Its primary sector is Cardiac and Vascular Disorders. In United States, the Cardiac and Vascular Disorders sector has seen $771M in funding in 2026 to date.

Where does Triomi rank among its competitors?

Triomi ranks 302nd amongst 230 active competitors, of which 54 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was LifeLens, which secured $15.1M in Nov, 2025.

Who are the top competitors of Triomi?

Triomi's top competitors include Eko, Powerful Medical and HeartFocus. Among them, LifeLens secured the most recent funding round in November, 2025.

Triomi - 2026 Company Profile, Team, Funding & Competitors

Triomi is a seed company based in New York City (United States), founded in 2010 by Sean Murphy and Amanda Zelman. It operates as a Provides point of care 12 lead ECG device. Triomi has raised an undisclosed amount in funding. The company has 230 active competitors, including 54 funded and 12 that have exited. Its top competitors include companies like Eko, Powerful Medical and HeartFocus.

Company Details

Triomi is a developer of mobile 12-lead EKG providing health practitioners with a clinical-grade 12-lead EKG at point-of-care. The device connects in real-time via bluetooth to any smartphone, tablet, or computer. The company also provides cardiologist interpretation of the results, and also allows results to be stored in the cloud.

Website: triomi.com
Social
Email ID: *****@triomi.com

Key Metrics

Founded Year

2010

Location

New York City, United States

Stage

Seed

Latest Funding Round

Seed, Mar 09, 2015, $*****

Investors

Techstars

Ranked

302^nd among 321 competitors

Similar Companies

Eko & 260 more

View Triomi's full profile

Triomi has raised funding over 1 round. Its latest funding round was a Seed round on Mar 09, 2015 for $*****. 1 investor participated in its latest round. Triomi has 1 institutional investor.

Here is the list of recent funding rounds of Triomi:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 09, 2015	4879328	Seed	4062734	6490113	8925596	6825505

Access funding benchmarks and valuations. Sign up today!

View details of Triomi's funding rounds and investors

The founders of Triomi are Sean Murphy and Amanda Zelman.

Here are the details of Triomi's key team members:

Sean Murphy: Founder & CTO of Triomi.
Contact Info: 1 email address
Amanda Zelman: Co-Founder of Triomi.
Contact Info: 1 email address

View details of Triomi's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Triomi include Eko, Powerful Medical and HeartFocus. Here is the list of Top 10 competitors of Triomi, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Eko 2012, Oakland (United States), Series D	Provider of AI-based remote patient monitoring platform for cardiac health	$195M	Artis Ventures, Peak XV Partners & 33 others	73/100
2nd	Powerful Medical 2019, Bratislava (Slovakia), Series A	Developer of AI-powered platform for interpreting electrocardiograms and detecting heart conditions	$11.4M	Venture to Future Fund, Europa & 6 others	67/100
3rd	HeartFocus 2023, Bordeaux (France), Seed	AI-driven app for healthcare professionals to perform cardiac ultrasound exams	$6M	Racine², BNP Paribas Developpement & 4 others	61/100
4th	Volta Medical 2016, Marseille (France), Series B	AI-based software developer for providing cardiac mapping assistance tools	$74.2M	Gilde Healthcare, Vensana Capital & 2 others	56/100
5th	VentriPoint 2005, Toronto (Canada), Public	Heart analysis system	-	-	56/100
6th	Laza Medical 2022, Los Gatos (United States), Series A	AI-powered robotically-assisted imaging solutions for cardiovascular interventions	$36M	The Capital Partnership, Shifamed & 5 others	54/100
7th	HeartSciences 2007, Austin (United States), Public	Provider of a screening device for the early detection of cardiac dysfunction	$31.7M	-	53/100
8th	LifeLens 2014, Warminster (United States), Series B	Developer of wireless ECG monitor for personal health monitoring use	$39.7M	Paragon Equity Partners, Brightstone Venture Capital ... Read more	52/100
9th	Keya Medical 2016, Seattle (United States), Series C	Provider of AI-based diagnosis tools for cardiologists	$30.2M	IDG Capital, Source Code Capital & 4 others	51/100
10th	Ventric Health 2014, Pasadena (United States), Seed	Provider of non-invasive device for cardiac disease diagnosis	$2.56M	-	49/100
302nd	Triomi 2010, New York City (United States), Seed	Provides point of care 12 lead ECG device	-	Techstars	15/100